Maria E. Di Battista
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.
Journal: Frontiers in immunology
Published: December 22, 2025
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Journal: Journal of neurology
Published: May 23, 2025
Epstein-Barr virus infection in patients with MOGAD.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 13, 2024
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis.
Journal: European journal of neurology
Published: October 11, 2024
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults' ischemic stroke.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 11, 2024
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Journal: Multiple sclerosis and related disorders
Published: February 01, 2024
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: May 30, 2023
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies.
Journal: Multiple sclerosis and related disorders
Published: August 30, 2022
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects.
Journal: Multiple sclerosis and related disorders
Published: March 09, 2022
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report.
Journal: Frontiers in neurology
Published: June 07, 2021
Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study.
Journal: Brain sciences
Published: June 04, 2021
Late-onset neutropenia (LON) recur in a MS patient after the second cycle of ocrelizumab: a case report.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 03, 2021
Last Updated: 09/26/2026